Abstract
The sigma-2 (σ2) receptor is proving to be an important protein in the field of cancer biology. The observations that σ2 receptors have a 10-fold higher density in proliferating tumor cells than in quiescent tumor cells, and that σ2 receptor agonists are capable of killing tumor cells via apoptotic and non-apoptotic mechanisms, indicate that this receptor is an important molecular target for the development of radiotracers for imaging tumors using techniques such as Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) and for the development of cancer chemotherapeutic agents. In spite of recent promising results towards achieving these goals, research in this field has been hampered by the fact that the molecular identity of the protein sequence of the σ2 receptor is currently not known. Consequently, most of what is known about this protein has been obtained using either radiolabeled or fluorescent probes for this receptor, or biochemical analysis of the effect of σ2 selective ligands on cells growing under tissue culture conditions. This article provides a review of the development and use of σ2 receptor ligands, and how these ligands have been used with a variety of in vitro and in vivo models to gain a greater understanding of the role this receptor plays in cancer.
Keywords: Sigma-2 receptors, cell proliferation, positron emission tomography
Central Nervous System Agents in Medicinal Chemistry
Title: Development of Molecular Probes for Imaging Sigma-2 Receptors in Vitro and in Vivo
Volume: 9 Issue: 3
Author(s): Robert Henry Mach and Kenneth Theodore Wheeler
Affiliation:
Keywords: Sigma-2 receptors, cell proliferation, positron emission tomography
Abstract: The sigma-2 (σ2) receptor is proving to be an important protein in the field of cancer biology. The observations that σ2 receptors have a 10-fold higher density in proliferating tumor cells than in quiescent tumor cells, and that σ2 receptor agonists are capable of killing tumor cells via apoptotic and non-apoptotic mechanisms, indicate that this receptor is an important molecular target for the development of radiotracers for imaging tumors using techniques such as Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) and for the development of cancer chemotherapeutic agents. In spite of recent promising results towards achieving these goals, research in this field has been hampered by the fact that the molecular identity of the protein sequence of the σ2 receptor is currently not known. Consequently, most of what is known about this protein has been obtained using either radiolabeled or fluorescent probes for this receptor, or biochemical analysis of the effect of σ2 selective ligands on cells growing under tissue culture conditions. This article provides a review of the development and use of σ2 receptor ligands, and how these ligands have been used with a variety of in vitro and in vivo models to gain a greater understanding of the role this receptor plays in cancer.
Export Options
About this article
Cite this article as:
Mach Henry Robert and Wheeler Theodore Kenneth, Development of Molecular Probes for Imaging Sigma-2 Receptors in Vitro and in Vivo, Central Nervous System Agents in Medicinal Chemistry 2009; 9 (3) . https://dx.doi.org/10.2174/1871524910909030230
DOI https://dx.doi.org/10.2174/1871524910909030230 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Whole is Just the Sum of its Parts: Limited Polydrug Use Among the “Big Three” Expensive Drugs in the United States
Current Drug Abuse Reviews Mechanistic Insights into Aspartame-induced Immune Dysregulation
Current Nutrition & Food Science Preface [Hot Topic: Transcription Factors as Targets of Novel Therapeutic Approaches of Autoimmune Diseases (Executive Editor: Gunther Ne)]
Current Pharmaceutical Design Nanoparticle-Mediated Delivery of Neuroprotective Substances for the Treatment of Diabetic Retinopathy
Current Neuropharmacology The 18-kDa Translocator Protein as a CNS Drug Target: Finding Our Way Through the Neuroinflammation Fog
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic: Oxidative Stress Induced-Metabolic Imbalance, Mitochondrial Failure, And Cellular Hypoperfusion As Primary Pathogenetic Factors For The Development Of Alzheimer Disease Which Can Be Used As An Alternate And Successful Drug Treatment Strategy: Past, Present And Future (Guest Editor: Gjumrakch Aliev)]
CNS & Neurological Disorders - Drug Targets Amyloid-Degrading Enzymes as Therapeutic Targets in Alzheimers Disease
Current Alzheimer Research Zn(L-proline)2: An Efficient and Recyclable Catalytic System for the Asymmetric Multicomponent Synthesis of 2-amino-4H-chromenes in Water Under Controlled Microwave Heating
Current Microwave Chemistry Recommendations for the Treatment of Hypertension in Patients with DM: Critical Evaluation Based on Clinical Trials
Current Clinical Pharmacology Alpha-Secretase As a Therapeutic Target
Current Alzheimer Research Therapies of Hematological Malignancies: An Overview of the Potential Targets and Their Inhibitors
Current Chemical Biology PKC Delta and Epsilon in Drug Targeting and Therapeutics
Recent Patents on DNA & Gene Sequences Chemical and Structural Features Influencing the Biological Activity of Curcumin
Current Pharmaceutical Design Status of Acetylcholinesterase and Butyrylcholinesterase in Alzheimer's Disease and Type 2 Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets Recent Developments in Deception Research
Current Psychiatry Reviews Dietary Approaches and Alternative Therapies for Polycystic Ovary Syndrome
Current Nutrition & Food Science New Targeted Treatments for Fragile X Syndrome
Current Pediatric Reviews Disorder in Milk Proteins: α-Lactalbumin. Part C. Peculiarities of Metal Binding
Current Protein & Peptide Science Survey of NMDA Receptor-related Biomarkers for Depression
Current Pharmaceutical Design What is the Current Role for Vitamin D and the Risk of Stroke?
Current Neurovascular Research